Botai has recently launched two high-performance pharmaceutical-grade Hydroxypropyl Methylcellulose (HPMC) products—E5 and E3. Leveraging differentiated viscosity properties and versatile functionalities, they provide innovative solutions for pharmaceutical formulations and daily chemical applications.

Core Product Characteristics

1. Botai HPMC E5

   • Medium-High Viscosity: Exhibits excellent suspension capabilities, thickening effects, and emulsifying performance.

   • Key Applications:

     • Serves as a multi-functional excipient, acting as a thickener, dispersant, emulsifier, and film-forming agent.

     • Used in tablet film coating and as an adhesive, significantly enhancing drug dissolution rates and improving tablet water resistance.

     • Combined with synthetic polymer gels in aqueous-alcoholic systems, it prevents syneresis (water separation) from transparent gels and improves water retention.

     • Extends to cosmetics and other daily chemical fields as an efficient thickener and raw material.

2. Botai HPMC E3

   • Low Viscosity: Possesses thickening, emulsifying, suspending, and gelling properties.

   • Key Applications:

     • Retains the multi-functional excipient properties of E5, with its low viscosity being particularly suitable for:

       • Acting as a pore-forming agent in sustained-release/controlled-release tablets.

       • Serving as a binder and disintegrant for tablets, pills, and granules.

     • Also functions effectively as a thickener and stability enhancer in daily chemical applications.

Industry Value

Both products meet stringent pharmaceutical-grade standards, addressing the dual demands for excipient safety and functionality in the pharmaceutical industry:

• E5 excels in tablet film coating and high-stability emulsification systems due to its medium-high viscosity.

• E3‘s low viscosity precisely addresses key challenges in controlled-release formulation processes, particularly for sustained-release applications.
  Concurrently, their use in cosmetics and personal care products further expands their market potential in areas like moisturization and texture modification.

Outlook

A spokesperson from Botai Technologies stated: “The synergistic deployment of E3 and E5 covers diverse scenarios—from immediate-release to sustained-release, and from pharmaceuticals to daily chemicals. We will continue optimizing our HPMC product series to provide global clients with higher-performance cellulose ether solutions.”